CuBaseBio

CubaseBio is a Stockholm-based spatial biology company founded by innovators in science and technology to build tools that reveal biology in three dimensions. The company has developed a next-generation platform for true 3D spatial transcriptomics — enabling researchers to analyze gene expression within intact tissue structures at scale, rather than relying on the thin 2D tissue sections used in conventional spatial techniques. CubaseBio's solution unlocks unprecedented biological insights and accelerates drug discovery by providing scalable, high-resolution spatial analysis of complex tissues. The company emerged from stealth in February 2026 with 5.9 million euros in blended financing.